AllayPay Expands U.S. Processing Support for RUO Peptide Merchants

PLANTATION, FL, UNITED STATES, September 30, 2026 /CourierPR/ -- AllayPay, a U.S.-based merchant services provider, has expanded its processing support for Research Use Only (RUO) peptide merchants in the United States. The new domestic program offers faster approvals, multiple payment options, and direct ISO underwriting support, addressing the long-standing challenges faced by these businesses.

Historically, RUO peptide merchants have struggled to secure stable, long-term payment processing. Mainstream processors often decline the category outright due to the regulatory and compliance complexity surrounding research-use-only products. Even when initial approvals are granted, processors may become uncomfortable as transaction volumes increase, leading to account closures. Offshore solutions, while available, come with slower funding, larger reserves, unexpected holds, and the constant risk of sudden account closures.

AllayPay, with nearly 11 years of experience in high-risk payment processing, has developed a program specifically tailored to the needs of RUO peptide merchants. The company works directly with qualified merchants and its banking partners to facilitate underwriting and account approval, offering faster processing times and more flexible terms.

According to the release, AllayPay's program provides the following benefits: - Domestic U.S. merchant processing for qualifying RUO peptide businesses, including MCC 5122 configurations where applicable. - Approvals in 1-2 business days for credit card processing and 2-3 business days for ACH processing. - A 97%+ authorization approval rate with standard 1-2-day funding. - Credit card, ACH, and eCheck processing under one account. - Integrations with major shopping carts, including WooCommerce, Shopify, BigCommerce, Magento, Ecwid, and many more. - Eligibility for startups with proper upfront reserves.

The program supports businesses across the peptide and research market, from manufacturers and suppliers to online retailers and companies offering peptide pharmaceuticals. It also includes support for businesses working with amino acids, GLP 1 compounds, semaglutides, and retatrutides, as well as eligible health providers offering peptide therapies.

AllayPay's direct ISO relationship allows the company to move quickly, provide clear answers, and give qualified merchants a more direct path to payment processing. The program requires a 5-10% rolling or upfront reserve based on volume and processing history, plus standard documentation such as government ID, a voided check or bank letter, and proof of a fulfillment agreement or owned inventory. Merchant websites must also meet RUO-specific standards, including age verification, a published lab report per product, account-only checkout, and scientific-only naming with no references to branded drugs.

AllayPay, Inc., a U.S. merchant services provider focused on high-risk and specialty industries, is a registered ISO/MSP of Fifth Third Bank, N.A., Cincinnati, OH, and maintains relationships with more than 30 acquiring banks. The company is dedicated to supporting the growing demand in the RUO peptide market, which has expanded quickly alongside consumer interest in GLP-1 and semaglutide-related compounds.